Compare Stocks: HIMS, TDOC, LLY, and NVO

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HIMS Hims & Hers Health	$19.73 0.0%	$27.61	$13.74 ▼ $40.99	$4.60B	2.53	15.21 million shs	10.01 million shs
LLY Eli Lilly and Company	$1,444.05 +1.2%	$1,242.25	$850.51 ▼ $1,460.00	$1.34T	0.4	3.00 million shs	2.08 million shs
NVO Novo Nordisk A/S	$41.65 +2.5%	$40.09	$35.12 ▼ $64.16	$181.50B	0.7	11.35 million shs	11.70 million shs
TDOC Teladoc Health	$8.81 +1.3%	$6.76	$4.40 ▼ $9.89	$1.58B	2	5.69 million shs	3.13 million shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HIMS Hims & Hers Health	0.00%	-23.98%	-33.21%	-29.93%	-49.41%
LLY Eli Lilly and Company	0.00%	+5.24%	+15.16%	+22.14%	+41.81%
NVO Novo Nordisk A/S	0.00%	+3.18%	+6.20%	-9.27%	-17.12%
TDOC Teladoc Health	0.00%	+0.11%	+48.13%	+29.03%	+17.87%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HIMS Hims & Hers Health	$19.73 0.0%	$27.61	$13.74 ▼ $40.99	$4.60B	2.53	15.21 million shs	10.01 million shs
LLY Eli Lilly and Company	$1,444.05 +1.2%	$1,242.25	$850.51 ▼ $1,460.00	$1.34T	0.4	3.00 million shs	2.08 million shs
NVO Novo Nordisk A/S	$41.65 +2.5%	$40.09	$35.12 ▼ $64.16	$181.50B	0.7	11.35 million shs	11.70 million shs
TDOC Teladoc Health	$8.81 +1.3%	$6.76	$4.40 ▼ $9.89	$1.58B	2	5.69 million shs	3.13 million shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HIMS Hims & Hers Health	0.00%	-23.98%	-33.21%	-29.93%	-49.41%
LLY Eli Lilly and Company	0.00%	+5.24%	+15.16%	+22.14%	+41.81%
NVO Novo Nordisk A/S	0.00%	+3.18%	+6.20%	-9.27%	-17.12%
TDOC Teladoc Health	0.00%	+0.11%	+48.13%	+29.03%	+17.87%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HIMS Hims & Hers Health	2.13	Hold	$31.53	59.86% Upside
LLY Eli Lilly and Company	2.83	Moderate Buy	$1,416.64	-1.90% Downside
NVO Novo Nordisk A/S	2.00	Hold	$59.44	42.70% Upside
TDOC Teladoc Health	2.17	Hold	$8.53	-3.09% Downside

Current Analyst Ratings Breakdown

Latest HIMS, TDOC, LLY, and NVO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
11/12/2026	LLY Eli Lilly and Company	China Merchants Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy ➝ Hold
11/10/2026	HIMS Hims & Hers Health	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Hold	$31.00 ➝ $24.00
11/10/2026	HIMS Hims & Hers Health	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Equal Weight	$28.00 ➝ $25.00
11/10/2026	HIMS Hims & Hers Health	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$42.00 ➝ $32.00
11/9/2026	LLY Eli Lilly and Company	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$1,610.00 ➝ $1,700.00
11/9/2026	TDOC Teladoc Health	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Hold	$6.00 ➝ $8.00
11/5/2026	TDOC Teladoc Health	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Equal Weight	$6.00 ➝ $8.00
11/4/2026	HIMS Hims & Hers Health	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D)
11/4/2026	TDOC Teladoc Health	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Equal Weight	$7.00 ➝ $9.00
11/2/2026	LLY Eli Lilly and Company	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Overweight	$1,440.00 ➝ $1,600.00
11/2/2026	TDOC Teladoc Health	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Neutral	$6.50 ➝ $9.00

(Data available from 11/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HIMS Hims & Hers Health	$2.35B	1.96	$0.84 per share	23.58	$1.52 per share	12.98
LLY Eli Lilly and Company	$65.18B	20.84	$25.43 per share	56.78	$42.81 per share	33.73
NVO Novo Nordisk A/S	$46.80B	3.97	$4.80 per share	8.67	$7.51 per share	5.55
TDOC Teladoc Health	$2.53B	0.63	$1.83 per share	4.82	$7.10 per share	1.24

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HIMS Hims & Hers Health	$128.37M	-$0.83	N/A	657.50	N/A	-6.65%	-9.62%	-1.38%	N/A
LLY Eli Lilly and Company	$20.64B	$30.81	46.87	28.48	1.71	31.90%	86.76%	22.03%	N/A
NVO Novo Nordisk A/S	$15.51B	$3.97	10.49	12.07	1.40	33.99%	53.52%	19.49%	N/A
TDOC Teladoc Health	-$200.32M	-$0.86	N/A	N/A	N/A	-6.27%	-11.63%	-5.53%	N/A

Latest HIMS, TDOC, LLY, and NVO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/9/2026	Q3 2026	HIMS Hims & Hers Health	$0.0563	$0.0280	-$0.0283	-$0.14	$893.13 million	$890.37 million
10/29/2026	Q3 2026	LLY Eli Lilly and Company	$5.71	$7.48	+$1.77	$7.22	$22.58 billion	$24.40 billion
10/28/2026	Q3 2026	TDOC Teladoc Health	-$0.2173	-$0.15	+$0.0673	-$0.15	$588.14 million	$605.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
LLY Eli Lilly and Company	$6.92	0.48%	+15.18%	22.46%	11 Years
NVO Novo Nordisk A/S	$0.82	1.97%	+21.74%	20.65%	N/A
TDOC Teladoc Health	N/A	N/A	N/A	N/A	N/A

Latest HIMS, TDOC, LLY, and NVO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
10/26/2026	LLY Eli Lilly and Company	quarterly	$1.73	0.48%	11/13/2026	11/13/2026	12/10/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HIMS Hims & Hers Health	3.85	0.92	0.87
LLY Eli Lilly and Company	1.17	1.39	1.00
NVO Novo Nordisk A/S	0.54	0.84	0.64
TDOC Teladoc Health	N/A	0.87	0.84

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HIMS Hims & Hers Health	63.52%
LLY Eli Lilly and Company	82.53%
NVO Novo Nordisk A/S	11.54%
TDOC Teladoc Health	76.82%

Insider Ownership

Company	Insider Ownership
HIMS Hims & Hers Health	11.76%
LLY Eli Lilly and Company	0.14%
NVO Novo Nordisk A/S	0.07%
TDOC Teladoc Health	0.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HIMS Hims & Hers Health	2,442	233.31 million	205.88 million	Optionable
LLY Eli Lilly and Company	50,000	940.74 million	939.43 million	Optionable
NVO Novo Nordisk A/S	69,505	4.47 billion	4.46 billion	Optionable
TDOC Teladoc Health	5,600	182.29 million	181.02 million	Optionable

HIMS, TDOC, LLY, and NVO Headlines

Recent News About These Companies

LifeStance, Private Equity Rollup Turned Organic Growth Stock, Targets A Profound Void

November 13 at 8:35 AM | finance.yahoo.com

Responsiv Announces New Healthcare & Insurance Offerings to Tackle Complex State-by-State Regulations

November 12 at 9:28 AM | finance.yahoo.com

Teladoc Health (NYSE:TDOC) Stock Price Expected to Rise, TD Cowen Analyst Says

November 11, 2026 | americanbankingnews.com

Head-To-Head Contrast: OptimizeRx (NASDAQ:OPRX) and Teladoc Health (NYSE:TDOC)

November 11, 2026 | americanbankingnews.com

Teladoc Health (NYSE:TDOC) Insider Carlos Nueno Sells 29,432 Shares of Company Stock

November 10, 2026 | insidertrades.com

Insider Selling: Teladoc Health (NYSE:TDOC) Insider Sells $270,774.40 in Stock

November 9, 2026 | marketbeat.com

How Teladoc Health Inc. (TDOC) Affects Rotational Strategy Timing

November 9, 2026 | news.stocktradersdaily.comN

Teladoc Health (NYSE:TDOC) Price Target Raised to $8.00

November 9, 2026 | marketbeat.com

Gabelli Releases Agenda for 8th Annual Healthcare Symposium

November 9, 2026 | finance.yahoo.com

Teladoc Health, Inc. (NYSE:TDOC) Stock Has Average Target Price of $8.40 According to Analysts

November 8, 2026 | americanbankingnews.com

Teladoc Health, Inc. (NYSE:TDOC) Stock Rated "Hold" by Wall Street Brokerages

November 8, 2026 | marketbeat.com

AI in Virtual Medical Assistants Market to Worth USD 8.85 Billion by 2030, at a CAGR of 36.6%– MarketsandMarkets™

November 6, 2026 | finance.yahoo.com

What Teladoc Health Bulls Got Right

November 6, 2026 | finance.yahoo.com

Teladoc Health (NYSE:TDOC) Stock Price Expected to Rise, Barclays Analyst Says

November 6, 2026 | americanbankingnews.com

Teladoc Health stock: Employee awards follow Teledigm deal

November 5, 2026 | ad-hoc-news.deA

Teladoc Health (NYSE:TDOC) Stock Price Target Raised at Wells Fargo & Company

November 5, 2026 | marketbeat.com

Teladoc Health (NYSE:TDOC) Stock Price Target Raised at Barclays

November 4, 2026 | marketbeat.com

Teladoc Health (NYSE:TDOC) Stock Rating Lowered by Argus

November 4, 2026 | americanbankingnews.com

Teladoc Health (NYSE:TDOC) Stock Gets Price Target Bump from Oppenheimer

November 4, 2026 | americanbankingnews.com

UBS Group Forecasts Strong Price Appreciation for Teladoc Health (NYSE:TDOC) Stock

November 4, 2026 | americanbankingnews.com

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

November 3, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HIMS, TDOC, LLY, and NVO Company Descriptions

Hims & Hers Health NYSE:HIMS

$19.73 -0.01 (-0.03%)

Closing price 11/13/2026 03:59 PM Eastern

Extended Trading

$19.39 -0.34 (-1.70%)

As of 11/13/2026 08:00 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Eli Lilly and Company NYSE:LLY

$1,444.05 +16.77 (+1.17%)

Closing price 11/13/2026 03:59 PM Eastern

Extended Trading

$1,438.50 -5.55 (-0.38%)

As of 11/13/2026 08:00 PM Eastern

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Novo Nordisk A/S NYSE:NVO

$41.65 +1.00 (+2.47%)

Closing price 11/13/2026 03:59 PM Eastern

Extended Trading

$41.40 -0.25 (-0.60%)

As of 11/13/2026 07:59 PM Eastern

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Teladoc Health NYSE:TDOC

$8.80 +0.12 (+1.32%)

Closing price 11/13/2026 03:59 PM Eastern

Extended Trading

$8.85 +0.04 (+0.50%)

As of 11/13/2026 07:54 PM Eastern

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIMS, TDOC, LLY, and NVO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIMS, TDOC, LLY, and NVO Earnings

Compare Dividends

Latest HIMS, TDOC, LLY, and NVO Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIMS, TDOC, LLY, and NVO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIMS, TDOC, LLY, and NVO Company Descriptions

Hims & Hers Health NYSE:HIMS

Eli Lilly and Company NYSE:LLY

Novo Nordisk A/S NYSE:NVO

Teladoc Health NYSE:TDOC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools